Dashboard
Manage Tickers

SLNOSOLENO THERAPEUTICS INC

Nasdaq soleno.life


$ 49.16 $ 1.69 (3.55 %)    

Thursday, 02-May-2024 15:59:51 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 429.07 $ 3.83 (0.9 %)
DIA $ 382.31 $ 3.34 (0.88 %)
SPY $ 505.01 $ 0.61 (0.12 %)
TLT $ 88.87 $ 0.31 (0.35 %)
GLD $ 213.12 $ -0.67 (-0.31 %)
$ 49.23
$ 47.58
$ 0.00 x 0
$ 0.00 x 0
$ 47.32 - $ 49.68
$ 3.48 - $ 53.82
307,794
na
811.91M
$ 3.10
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-07-2024 12-31-2023 10-K
2 11-07-2023 09-30-2023 10-Q
3 08-08-2023 06-30-2023 10-Q
4 05-09-2023 03-31-2023 10-Q
5 03-22-2023 12-31-2022 10-K
6 11-09-2022 09-30-2022 10-Q
7 08-10-2022 06-30-2022 10-Q
8 05-10-2022 03-31-2022 10-Q
9 03-31-2022 12-31-2021 10-K
10 11-10-2021 09-30-2021 10-Q
11 07-28-2021 06-30-2021 10-Q
12 05-05-2021 03-31-2021 10-Q
13 03-03-2021 12-31-2020 10-K
14 11-10-2020 09-30-2020 10-Q
15 08-10-2020 06-30-2020 10-Q
16 05-12-2020 03-31-2020 10-Q
17 03-04-2020 12-31-2019 10-K
18 11-13-2019 09-30-2019 10-Q
19 08-07-2019 06-30-2019 10-Q
20 05-13-2019 03-31-2019 10-Q
21 03-20-2019 12-31-2018 10-K
22 11-14-2018 09-30-2018 10-Q
23 08-14-2018 06-30-2018 10-Q
24 05-15-2018 03-31-2018 10-Q
25 04-02-2018 12-31-2017 10-K
26 11-14-2017 09-30-2017 10-Q
27 08-11-2017 06-30-2017 10-Q
28 05-11-2017 03-31-2017 10-Q
29 03-15-2017 12-31-2016 10-K
30 11-14-2016 09-30-2016 10-Q
31 08-12-2016 06-30-2016 10-Q
32 05-12-2016 03-31-2016 10-Q
33 03-25-2016 12-31-2015 10-K
34 11-12-2015 09-30-2015 10-Q
35 08-10-2015 06-30-2015 10-Q
36 05-04-2015 03-31-2015 10-Q
37 03-13-2015 12-31-2014 10-K
38 12-18-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

soleno-therapeutics-announces-proposed-public-offering-of-common-stock-no-size-or-amount-disclosed
Soleno Therapeutics Announces Proposed Pub...
05/02/2024 20:41:22

Soleno Therapeutics, Inc. (NASDAQ:SLNO), ("Soleno" or the "Company"), a clinical-stage biopharmaceutical compan...

soleno-therapeutics-announces-peer-reviewed-publication-of-data-comparing-dccr-treatment-to-the-natural-history-of-prader-willi-syndrome
Soleno Therapeutics Announces Peer-Reviewe...
04/30/2024 12:15:19

Soleno Therapeutics, Inc. (Soleno) (NASDAQ:SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for ...

us-stocks-kick-off-the-week-in-the-green-tesla-rockets-on-chinas-fsd-approval-yen-rallies-whats-driving-markets-monday
US Stocks Kick Off The Week In The Green, ...
04/29/2024 18:14:53

U.S. stocks kicked off the week on a positive note, with all major averages edging higher in anticipation of significant events...

Core News & Articles
Why Clever Leaves Holdings Shares Are Trad...
04/29/2024 17:04:01

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
04/29/2024 16:31:20

tesla-deciphera-pharmaceuticals-heartland-financial-and-other-big-stocks-moving-higher-on-monday
Tesla, Deciphera Pharmaceuticals, Heartlan...
04/29/2024 14:47:40

soleno-therapeutics-receives-breakthrough-therapy-designation-from-fda-for-dccr-extended-release-tablets-in-prader-willi-syndrome
Soleno Therapeutics Receives Breakthrough ...
04/29/2024 12:02:15

First Ever Breakthrough Designation for a Drug Being Developed for PWSDesignation is Based on Data from the Phase 3 Program for...

soleno-therapeutics-q4-eps-033-misses-027-estimate
Soleno Therapeutics Q4 EPS $(0.33) Misses ...
03/06/2024 21:24:12

Soleno Therapeutics (NASDAQ:SLNO) reported quarterly losses of $(0.33) per share which missed the analyst consensus estimate of...

piper-sandler-initiates-coverage-on-soleno-therapeutics-with-overweight-rating-announces-price-target-of-93
Piper Sandler Initiates Coverage On Soleno...
02/05/2024 11:14:44

Piper Sandler analyst Yasmeen Rahimi initiates coverage on Soleno Therapeutics (NASDAQ:SLNO) with a Overweight rating and an...

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
01/29/2024 21:31:25

stifel-initiates-coverage-on-soleno-therapeutics-with-buy-rating-announces-price-target-of-63
Stifel Initiates Coverage On Soleno Therap...
01/23/2024 09:39:10

Stifel analyst Dae Gon Ha initiates coverage on Soleno Therapeutics (NASDAQ:SLNO) with a Buy rating and announces Price Targ...

soleno-therapeutics-inc-files-for-mixed-shelf-size-not-disclosed
Soleno Therapeutics Inc Files For Mixed Sh...
01/02/2024 22:05:21

- SEC Filing

oppenheimer-maintains-outperform-on-soleno-therapeutics-raises-price-target-to-47
Oppenheimer Maintains Outperform on Soleno...
01/02/2024 16:49:18

Oppenheimer analyst Leland Gershell maintains Soleno Therapeutics (NASDAQ:SLNO) with a Outperform and raises the price targe...

forget-the-magnificent-7-did-anyone-back-these-1000-gainers-in-2023
Forget The Magnificent 7: Did Anyone Back ...
12/28/2023 19:09:49

Baron Fifth Avenue Growth Fund gained nearly 60% over the year, while the Fidelity Blue Chip Growth ETF climbed 59%.

these-two-companies-surpass-nvidia-apple-and-microsoft-with-astounding-1000-returns-in-2023
These Two Companies Surpass Nvidia, Apple ...
12/28/2023 08:12:35

The two companies outperformed the 'Magnificent Seven' group of stocks, which includes tech giants such as Nvidia, Appl...

4-analysts-have-this-to-say-about-soleno-therapeutics
4 Analysts Have This to Say About Soleno T...
11/21/2023 18:00:42

soleno-therapeutics-q3-eps-095-misses-058-estimate
Soleno Therapeutics Q3 EPS $(0.95) Misses ...
11/07/2023 13:09:01

Soleno Therapeutics (NASDAQ:SLNO) reported quarterly losses of $(0.95) per share which missed the analyst consensus estimate of...

soleno-therapeutics-announces-peer-reviewed-publication-of-results-from-long-term-open-label-study-of-dccr-in-prader-willi-syndrome
Soleno Therapeutics Announces Peer-Reviewe...
11/06/2023 13:44:40

Soleno Therapeutics, Inc. ("Soleno") (NASDAQ:SLNO), a clinical-stage biopharmaceutical company developing novel therape...

soleno-therapeutics-inc-files-prospectus-relates-to-resale-by-selling-stockholders-of-up-to-3m-shares-of-common-stock
Soleno Therapeutics Inc Files Prospectus R...
10/20/2023 20:36:06

- SEC Filing

Core News & Articles
Soleno Therapeutics 13G Filing Shows Janus...
10/06/2023 15:48:52

- SEC Filing

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION